10030-93-0

Basic information

• Product Name: TRI-ACETYL PYRIDOXINE
• Synonyms: TRI-ACETYL PYRIDOXINE
• CAS NO: 10030-93-0
• Molecular Formula: C₁₄H₁₇NO₆
• Molecular Weight: 295.29
• Mol File: 10030-93-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: TRI-ACETYL PYRIDOXINE(CAS DataBase Reference)
• NIST Chemistry Reference: TRI-ACETYL PYRIDOXINE(10030-93-0)
• EPA Substance Registry System: TRI-ACETYL PYRIDOXINE(10030-93-0)

Safety Data

• Hazardous Substances Data: 10030-93-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
TRI-ACETYL PYRIDOXINE is used as a supplement for treating vitamin B6 deficiency, ensuring the body has adequate levels of this essential nutrient to support various physiological processes.
Used in Neurological Applications:
TRI-ACETYL PYRIDOXINE is used as a therapeutic agent for epilepsy, where it has shown potential in reducing the frequency and severity of seizures by modulating neurotransmitter synthesis and function.
Used in Endocrine Applications:
In the treatment of diabetes, TRI-ACETYL PYRIDOXINE is used to support insulin production and glucose metabolism, helping to manage blood sugar levels and reduce the risk of complications associated with diabetes.
Used in Cardiovascular Applications:
TRI-ACETYL PYRIDOXINE is used to support cardiovascular health by potentially reducing the risk of heart disease through its involvement in lipid metabolism and the maintenance of healthy blood vessels.
Overall, TRI-ACETYL PYRIDOXINE is a versatile compound with significant applications across various medical and health-related fields, offering promising benefits for the prevention and treatment of a range of conditions.

Upstream product

• 58-56-0 pyridoxal hydrochloride 
• 108-24-7 acetic anhydride 
• 39984-49-1 2-Methyl-3-hydroxy-4,5-bis-(bromomethyl)-pyridine hydrobromide 
• 65-23-6 5-hydroxy-6-methyl-3,4-pyridinedimethanol 

Downstream Products

• 85-87-0 pyridoxamine 
• 58-56-0 pyridoxal hydrochloride 

Relevant articles and documents

Lipase-catalyzed acylation and deacylation reactions of pyridoxine, a member of vitamin-B6 group

A series of acyloxy derivatives of pyridoxine (1) have been prepared by transesterification reactions of 1 and ethyl carboxylates, catalyzed by several lipases. Moreover, acetylated derivatives of 1 were selectively deacetylated by enzymatic catalysis in organic media.

MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME

Multibiotic agents are disclosed. The multibiotic agents may contain two or more moieties linked through bonds cleavable in vivo. The bonds cleavable in vivo can be ester bonds, amide bonds, azo bonds, glycosidic bonds, carbonate linkers, or carbamate linkers. The moieties can be alcohol cores, amine cores, and/or acyls. Also disclosed are compositions containing multibiotic agents and methods of using the multibiotic agents.

METHODS FOR THE SYNTHESIS OF PYRIDOXAMINE

The invention provides non-oxidative methods for the large scale manufacture of pyridoxamine (I) (4-aminomethyl-3-hydroxy-5-hydroxymethyl-2-methylpyridine): Formula (I), and salts thereof. The invention also provides intermediate compounds for the synthesis of pyridoxamine, as well as compositions and methods for the treatment and/or prevention of conditions associated with the formation of post-Amadori advanced glycation end-products.

1,3 DIHYDROFURO [3,4-c]PYRIDINES AND THEIR PREPARATION

The present invention relates to novel 1,3-dihydrofuro[3,4-c]pyridines which are useful intermediates in the synthesis of pyridoxines and a method for their preparation by cobalt(I) complex-catalysed [2 + 2 + 2]-cycloaddition of di-[(3-dimethyl-C1-4-alkoxysilyl)-2-propynyl)] ethers with acetonitrile.

Manufacture of pyridoxin

An industrially advantageous process for the manufacture of vitamin B6 (pyridoxin) from 2-methyl-3-hydroxy-4,5-bis-(halomethyl)-pyridine, wherein the starting compound is first converted in the conventional manner to the corresponding pure acetoxy compound which is reacted with an alkali metal acetate, alkaline earth metal acetate or tertiary ammonium acetate to give pyridoxin triacetate, from which pyridoxin can be liberated by hydrolysis or trans-esterification.